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The peroxidation of lipids in biological membranes is a destructive phenomenon that can he elicited in 
various ways. Surface receptor molecules that allow ceffs to respond to hormones are possibly inactivated 
during lipid peroxidation. Effects of lipid peroxidation on receptors have not been extensively examined 
thus far. This investigation shows that there is a decrease in fi-adrenoceptor density (measured as specific 
( -)-(125i]iodocyanopindoloi binding) during lipid peroxidation, in both lungs and erythrocytes of the rat. 
To this end, lung membranes (containing both /I,- and b,-adrenoeeptors) and intact erythrocytes (containing 
a homogeneous /3,-adrenoceptor population) were pretreated with cumene hydroperoxide (lung membranes 
with 0.1 mM and erythrocytes with 1 mM) and Fez+ (1 x 10e5 M) for 40 min which resulted in extensive 
lipid peroxidation measured as malondialdehyde formation. The ratio fl,-:/I,-adrenoceptor density in lung 
membranes after treatment with cumene hydroperoxide did not change and remained at 305~70%. A single 
injection (i.p.) with the herbicide paraquat (50 mg/kg, 24 h), which is known to cause Lung damage via lipid 
peroxidation, resuhed in similar alterations in receptor density to those caused by cumene hydroperoxide 
in the in vitro experiments. 
1. INTRODUCTION 
Lipid peroxidation has been defined as the ‘ox- 
idative deterioration of polyunsaturated lipids’, 
i.e. lipids that contain more than two carbon- 
carbon double bonds [ 11. Because the membranes 
surrounding cells and cell organelles contain large 
amounts of polyu~aturated fatty acid side chains, 
most of the interest in this subject in the literature 
has been focus& on polyunsaturated fatty acids. 
Lipid peroxidation of polyunsaturated fatty acids 
leads to the formation of malondialdehyde, a 
product known to be toxic to a variety of 
biological systems [2-51. Malondialdehyde is 
farmed directly from peroxy (free) radicals and in- 
teracts with a variety of cellular constituents to 
form polymers that are believed to play a role in 
formation of age-reIated lipopigments [S]. Oxygen 
radicals have been suggested as a major cause of 
some heart and lung diseases and aging. Oxygen 
radicals and other oxidants appear to be toxic in 
large part because they initiate the chain reaction 
of lipid peroxidation. This process changes all 
kinds of enzymatic reactions. We investigated the 
effect of lipid peroxidation on P-adrenoceptors of 
lungs and erythrocytes of the rat, both in vitro and 
in vivo. To this end we pretreated lung membranes 
and intact erythrocytes in vitro with cumene 
hydroperoxide and Fez+, which resulted in exten- 
sive lipid peroxidation. In the in vivo situation we 
administered a single injection (i.p.) of the her- 
bicide paraquat, which is known to cause lung 
damage via lipid peroxidation ]S,7], and studied& 
adrenoceptor density after 24 h. The effect of lipid 
peroxidation on ,&adrenoceptors of lungs &$i and 
p2) and erythrocytes @z) of the rat was measured 
with a receptor-binding assay using ( -)-[‘251]iodo- 
cyanopindolol [8]. 
2. MATERIALS AND METHODS 
2.1_ Pr~~~r~~j~~ aEd ~~~~~~~~~~ 0f ~y~~~~~~~~ 
After decapitation of male Wistar rats of 
ISO-20 g, the blood was collected in heparin 
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tubes (Greiner, Alphen a/d Rijn, The Netherlands} 
and centrifuged (3000 rpm, 3 min). The superna- 
tant was removed and 6 ml buffer A, containing 
140 mM NaCl, 50 mM Tris and 5 mM MgCl2 (pH 
7.4 at O”C), was added. This was repeated 3 times 
at 4’C. The final pellet of blood was suspended in 
buffer A (1: 16, pH 7.4 at 37°C) and pretreated 
with 1 mM cumene hydroperoxide and Fe” (1 x 
low5 M) for 60 min at 37°C. After this incubation, 
the erythrocytes were lysed with IO mM phosphate 
buffer (pH 7.4) for 5 min at 4°C and centrifuged 
at 50000 x g for 30 min at 4°C. This procedure 
was repeated 3 times. The receptor-binding assay 
was performed with membranes (4-1Opg pro- 
tein/ml) suspended in buffer A (pH 7.4 at 37°C). 
2.4. ~eterm~nafion of maIo~dia~dehyde and 
protein 
Lipid peroxidation was assayed by measuring 
thiobarbituric acid (TBA)-reactive material. An 
aliquot of the incubation mixture (0.3 ml) was 
stopped by mixing with ice-cold TBA-trichloro- 
acetic acid-HCl-butylhydroxytoluene (BHT) solu- 
tion (2 ml). After heating (15 min, SO’C) and cen- 
trifugation (15 min) the absorbance at 535 nm vs 
600 nm was determined. The TBA-trichforoacetic 
acid-HCI solution was prepared by dissolving 
41.6 mg TBA/lO ml trichloroa~etic acid (16.8%, 
w/v in 0.25 N HCl). To 10 ml TBA-trichloroacetic 
acid-NC1 1 ml BHT (1.5 mg/ml ethanol) was add- 
ed. The added chemicals did not interfere with the 
assay at the concentrations used. Protein was 
assayed as in [9], using bovine serum albumin as a 
standard. 2.2. Preparation and incubation of lung 
membranes 
After decauitation of male Wistar rats of 
180-200 g, ;he lungs were removed and 
homogenized in buffer A (1 g lung in 3 ml buffer 
A, pH 7.4 at 37°C) with a Polytron (PT 10135) 
homogenizer (1 x 15 s, max. speed). This crude 
preparation was centrifuged for 20 min at 10~ x 
g. The supernatant was centrifuged for 60 min at 
50000 x g. The pellet obtained was washed in buf- 
fer A (pH 7.4 at O’C) and homogenized (1 min, 
max. speed). The whole procedure was performed 
at 4°C. This final pellet was taken up in buffer A 
(pH 7.4 at 37”C, 1: 15) and pretreated with 
0.1 mM cumene hydroperoxide and Fe*+ (I x 
10m5 M) for 60 min at 37°C. After the incubation, 
buffer A (pH 7.4 at 0°C) was added (1: 10) and 
cen~ifugation at 50000 x g for 30 min followed. 
After homogenization of the pellet (1 min, max. 
speed) a second centrifugation was carried out. 
The receptor-binding assay was performed using 
membranes (15-21 gg protein/ml) suspended in 
buffer A (pH 7.4 at 37’C). 
2.3. Pretreatment with paraquat 
A group of male Wistar rats (180-200 g) were 
pretreated with a single injection (i.p.) of 
50 mg/kg with the herbicide paraquat, The control 
group was pretreated with a physiological salt solu- 
tion 161. After 24 h the rats were decapitated, the 
blood collected and the lungs removed. Prepara- 
tion of erythrocyte membranes and of the lungs 
was performed as described above. 
2.5. Receptor- binding assay 
All assays were performed in triplicate in a final 
volume of 350 pl. For the saturation experiments 
the lung membranes and erythrocytes were in- 
cubated for 60 min at 37°C with (-)-[‘251]iodo- 
cyanopindolol (O-ZOO pmob’l). In all experiments 
non-specific binding was determined with 10V6 M 
timolol. At the end bound and free ligands were 
separated by dilution of the sample with 4 ml cold 
buffer A (pH 7.4 at OOC), followed by rapid filtra- 
tion through Whatman G/FC filters on a Millipore 
vacuum fiitrator. Each fiiter was washed twice 
with 4 ml cold buffer A and counted for radioac- 
tivity using an Auto-Gamma scintillation spec- 
trometer (Packard, USA). 
2.6. Analysis of data 
Bmax values (fmol/mg protein) and dissociation 
constants, & (PM), were evaluated from the 
binding data, according to the model based on the 
first-order mass action law for multiple binding 
sites. This was done with the non-linear curve- 
fitting program (LIGAND) [lo] on a Zenith Z-l 10 
microcomputer. This program provides a correc- 
tion for real free ligand concentrations on non- 
specific binding and a statistically reliable analysis 
of binding data. Fits for multiple binding sites 
were considered significantly best when the P value 
for a single binding site was less than 0.05. 
81 
Volume 198, number 1 FEBS LETTERS March 1986 
2.7. Chemiculs 
Drugs used were: (-)-timolol (Merck, Sharp 
and Dohme); ICI 89,406 (ICI); cumene 
hydroperoxide (ICN, Rare and Fine Chemicals); 
paraquat (Sigma); FeS04 (Merck); (-)-[?]iodo- 
cyanopindolol (spec. act. 1800 Ci/mmol) (New 
England Nuclear). All other reagents used were of 
reagent grade. 
3. RESULTS 
Fig.1 shows that incubation of erythrocytes or 
lung membranes with cumene hydropero~de and 
Fe’+ results in time-dependent formation of TBA- 
reactive material, which is mainly malon- 
dialdehyde. Fig.2 shows the changes in the satura- 
tion of iodocyanopindolol binding to the 
homogeneous population of ,&-adrenoceptors on 
the membranes of erythrocytes, due to pretreat- 
ment of intact erythrocytes with cumene 
hydroperoxide (1 mM) and Fe’+ (1 x 10e5 M). 
Analysis of the binding data resulted in a Kd of 26 
* 4 pM and a BmaX of 947 + 72 fmol/mg protein 
for membranes of control erythrocytes and a Kd of 
42 f 10 pM and a Bmax of 307 zt 42 fmol/mg pro- 
tein for membranes of cumene hydroperoxide of 
pretreated erythrocytes. Pretreatment of lung 
membranes with cumene hydraperoxide (0.1 mM) 
and Fe’+ (1 x 10m5 M) for 60 min also produced 
Fig. I. Formation of TBA-reactive material during 
incubation with cumene hydroperoxide and Fe2+. (n) 
Erythrocytes (61-64 pg protein/ml) with 1 mM cumene 
hydroperoxide and 1 x lo-’ M Fe’+. (m) Lung 
membranes (lOO-107gg protein/ml) with 0.1 mM 
cumene hydroperoxide and I x lo-’ M Fe*‘. 
Fig.2. Specific binding of increasing concentrations of 
iodocyanopindolol (ICYP) in erythrocyte membranes. 
Control erythrocytes (m) or membranes of erythrocytes 
pretreated with 1 mM cumene hydroperoxide and Fe’+ 
(1 x lo-’ M) (0). Incubation took place with “‘ICYP 
for 60 min at 37°C. Non-specific binding was 
determined by addition of 10m6 M timolol. Control (m), 
Kd = 26 + 4 pM and B,,, = 947 f 12 fmol/mg protein; 
with cumene hydroperoxide (q ), Ka = 42 rt 10 pM and 
B max = 307 t 47 fmollmg protein. The results were 
obtained by a simultaneous fit of two experiments. 
changes in both P-adrenoceptor density (Bmax) and 
dissociation constant (&) (table 1). 
It is known that lung membranes contain both 
PI- and Pz-adrenoceptors. Here we used the selec- 
tive Pt-adrenergic ligand ICI 89,406 to quantify 
the PI- and .&-receptor populations (fig.3). The 
ratio PI-:,&-adrenoceptor density in lung mem- 
branes after in vitro treatment with cumene 
hydroperoxide did not change and remained at 
30% : 70%. 
Table I 
Binding characteristics of ICYP to lung membranes of 
the rat with or without pretreatment with cumene 
hydroperoxide 
Pretreatment Kd (PM) B max 
(fmol/mg protein) 
- 112 * 11 1250 f 96 
Cumene hydro- 
peroxide 82~ 5 881 t 37 
Results ( f SE) were obtained by simultaneous fitting of 
two independent experiments 
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Fig.3. ~e~erm~n~tion of the ratio ~I-:~~-adreno&~tor 
density by dispIa~em~nt of specific binding of ICYP 
(35 PM) by pi-selective adrenergic iigand ICI 89,406 
from either control (0) or cumene hydroperoxide 
(0.1 mM) and Fe’+ (I x IO-” M) (o)-pretreated lung 
membranes. Curves were drawn after computer analysis. 
Ratio of pr $32: (control) 28 ~?r 5% :72 4 4% and 
(pretreated) 32 + 6t’lo : 68 t 4%. 
Lipid peroxidation initiated in viva by a single 
paraquat ad~~stration (in.. 50 mg/kg, 24 h) 
resulted in a decrease in specific (- )-[rzsI]iodu- 
cyanopindolol binding in lung membranes as in- 
dicated in table 2, Also, membranes of 
erythrocytes possess less @-adrenoceptors after 
paraquat pretreatment, whereas the & Value re- 
mained identical. Analysis of the binding data 
resulted in a Bmax and a & of 432 i 14 fmol/mg 
protein and 24 + 2 pM in control and 284 rt 
21 fmol/mg protein and 23 f 4 pM, respectively, 
after paraquat pretreatment. 
Table 2 
Binding characteristics of ICYP to lung membranes of 
the rat with or without pretreatment with paraquat 
Pretreatment 
_.~~_ 
Kd (PM) B max 
(fmol/mg protein) 
85 f i6 1967 + 371 
Paraquat 532 5 1561 4 99 
The result is from a representative xperiment f SE 
Fig.4 Specific binding of increasing concentrations of 
ICYP in erythrocyte membr~es. Erythrocytes were 
obtained from either control rats (ct) or rats pretreated 
with paraquat (0) (SO mgikg, 24 h). Incubation took 
place with ICYP for 60 min at 37°C. Non-specific 
binding was determined by the addition of IO-* M 
timolol. Control ( q ), Kd = 24 + 2 pM and Bmax = 432 I: 
14 fmol/mg protein; pretreated with paraquat fo), & = 
23 rt 4 pM and f3max = 284 + 21 fmob’mg protein. A 
representative xperiment is shown, 
The major constituents of bio~ogic~ membranes 
are lipids and proteins. It is well known that the 
process of lipid peroxidation can damage these 
membrane constituents. Here, we found a decrease 
in both affinity (Kd values) and number of & 
adrenoceptors (Sr,,, values) after lipid peroxida- 
tion both in vitro and in vivo. This can be explain- 
ed by general deterioration of the membrane, 
Moreover, it is known that the&adrenoceptors re- 
tain essential sul~ydryl groups [II]_ Our results 
may therefore also be explained by means of the 
effect of aldehydes which are formed during lipid 
peroxidation and may interact with sulfhydryX 
moieties of @-adrenoceptors. ,6’1- and ,&adre- 
noceptors seem to be equally sensitive to lipid 
peroxidation, since the ratio PI-:&-adrenoceptors 
remained the same after lipid peroxidatio~ in lung 
membranes. 
Our results also provide an explanation for the 
observations by Engels et al. 1121, who reported a 
decrease in tracheal relaxation in response to 
isoproterenol by oxygen radicals produced by 
macrophages. 
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Other types of receptors may also be affected by 
free radkals. ft has been found 1131 that specific 
birding of 5-~~~~hydrox~r~t~i~e to washed 
ascarbate-pretreated corticaf membranes af the rat 
was ~~~nificant1~ lower than their incubated con- 
trols. It has been recently reported 1141 that 
pretreatment of the cerebral synaptic membranes 
with hydrogen peroxide resulted in a significant 
suppression of specific binding of [%]muscimol, 
which is a radioligand for the r-aminobutyric acid 
receptor. Based on our results, an overall decrease 
in ~-receptor-mediate response should be ex- 
pected after lipid ~eroxidatio~. This may have im- 
portant implications in ~atho~hysiolo~i~~ condi- 
tions in which Iipid ~roxidatio~ is thought to play 
an essential role. For example, lipid peroxidation 
has been associated with aging [l$,lriJ, and in fact 
the &receptor response decreases with age [ 171. 
Also, tissue damage induced by ischemia or hypox- 
ia has been suggested to be due to oxidative stress 
[lg].. Alterations in &receptor response under 
these conditions have not been examined thus far. 
The toxicity of many compounds, like paraquat, 
has been shown to proceed via lipid ~roxidation~ 
Iiere we found aiterations in both ~-adreno~e~tor 
density in tungs as weff as in erythrocytes after ad- 
ministration of the herbicide paraquat. ft is possi- 
bie that the changes observed in ~rytbro~~es mere- 
ly form a reflection of the severe lung damage in- 
duced by the high dosage of paraquat. It has been 
suggested that the effect of oxidative Stress in lungs 
is partly diminished by the protective action of 
blood cells [ 191. Because blood cells are easily ob- 
tainable, also in the case of humans, it should be 
i~t~~~stin~ to elucidate these secondary changes in 
erythrocytes further. This therefore constitutes 
part of our present investigations. 
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